RT Journal Article
SR Electronic
T1 Post-COVID-19 syndrome in outpatients: a cohort study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.19.21255742
DO 10.1101/2021.04.19.21255742
A1 Florian Desgranges
A1 Eliana Tadini
A1 Aline Munting
A1 Jean Regina
A1 Paraskevas Filippidis
A1 Benjamin Viala
A1 Eleftherios Karachalias
A1 Véronique Suttels
A1 David Haefliger
A1 Eleftheria Kampouri
A1 Mathias Van Singer
A1 Jonathan Tschopp
A1 Laurence Rochat Stettler
A1 Siméon Schaad
A1 Thomas Brahier
A1 Olivier Hugli
A1 Yolanda Mueller Chabloz
A1 Alexandre Gouveia
A1 Onya Opota
A1 Pierre-Nicolas Carron
A1 Benoît Guery
A1 Matthaios Papadimitriou-Olivgeris
A1 Noémie Boillat-Blanco
A1 the RegCOVID research group.
YR 2021
UL http://medrxiv.org/content/early/2021/04/20/2021.04.19.21255742.abstract
AB Background Some patients experience long-term symptoms after COVID-19, but data on outpatients with mild-to-moderate COVID-19 are scarce.Objective To describe persisting symptoms more than 3 months after infection in PCR-confirmed COVID-19 in comparison to negative SARS-CoV-2 PCR outpatients and to identify predictors of long-term symptoms in COVID-19.Setting Outpatient clinics of a Swiss university center.Patients 418 symptomatic outpatients with PCR-confirmed COVID-19 (COVID-positive) and 89 negative SARS-CoV-2 PCR (COVID-negative).Design Prospective cohort study.Measurements Predefined long-term symptoms were evaluated though a phone interview >3 to 10 months after diagnosis.Associations between long-term symptoms and PCR test result, as well predictors of persisting symptoms in COVID-positive were evaluated by multivariate logistic regression including potential confounders (age, sex, smoking, comorbidities, time of the phone survey).Results The study population consisted mostly of young (median of 41 versus 36 years in COVID-positive and COVID-negative, respectively; p=0.020) health care workers (67% versus 82%; p=0.006).. Persisting symptoms were reported by 223 (53%) COVID-positive and 33 (37%) COVID-negative (p=0.006). Overall, 21% COVID-positive and 15% COVID-negative (p=0.182) consulted a doctor for these symptoms. Four surveyed symptoms were independently associated with COVID-19: fatigue (adjusted odds ratio [aOR] 2.14, 95%CI 1.04-4.41), smell/taste disorder (26.5, 3.46-202), dyspnea (2.81, 1.10-7.16) and memory impairment (5.71, 1.53-21.3). Among COVID-positive, female gender (aOR 1.67, 95% CI 1.09-2.56) and overweight/obesity (1.67, 1.10-2.56) were predictors of persisting symptoms.Limitations Undiagnosed SARS-CoV-2 infection in COVID-negative cannot be completely excluded.Conclusion More than half of COVID-positive outpatients report persisting symptoms up to 10 months after infection and 21% seek medical care for this reason. These data suggest that post-COVID syndrome places a significant burden on society and especially healthcare systems.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by an academic award of the Leenaards Foundation (to NBB), the Infectious Disease Service and the emergency department of Lausanne University Hospital. The funding bodies had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscriptAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The project was approved by the Ethics Committee of the Canton of Vaud, Switzerland (project-ID CER-VD 2020-01107 and 2019-02283).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author, FD, upon reasonable request.